Literature DB >> 228203

Apamin blocks certain neurotransmitter-induced increases in potassium permeability.

B E Banks, C Brown, G M Burgess, G Burnstock, M Claret, T M Cocks, D H Jenkinson.   

Abstract

Apamin is a neurotoxic polypeptide of known structure isolated from bee venom. Shuba and coworkers have recently shown that it abolishes the hyperpolarising action of externally-applied ATP on visceral smooth muscle (guinea pig stomach and taenia coli) as well as the hyperpolarisation (inhibitory junction potential) that follows stimulation of the non-adrenergic inhibitory nerve supply to these tissues. As it has been proposed that ATP is the neurotransmitter involved in the latter response, Vladimirova and Shuba tentatively concluded that apamin is a specific postsynaptic blocking agent of this non-adrenergic, possibly 'purinergic', inhibition. We have confirmed the important observation that nanomolar concentrations of apamin reduce inhibition by ATP and by non-adrenergic nerve stimulation, but further experiments suggest that, rather than acting as a specific blocker of ATP receptors, apamin inhibits the increase in potassium permeability caused by a number of agents, including ATP.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 228203     DOI: 10.1038/282415a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  109 in total

1.  Activation of small conductance Ca(2+)-dependent K+ channels by purinergic agonists in smooth muscle cells of the mouse ileum.

Authors:  F Vogalis; R K Goyal
Journal:  J Physiol       Date:  1997-08-01       Impact factor: 5.182

2.  Role of nitric oxide in non-adrenergic, non-cholinergic inhibitory junction potentials in canine ileocolonic sphincter.

Authors:  S M Ward; E S McKeen; K M Sanders
Journal:  Br J Pharmacol       Date:  1992-04       Impact factor: 8.739

3.  Mechanical, electrical and cyclic nucleotide responses to peptide VIP and inhibitory nerve stimulation in rat stomach.

Authors:  S Ito; A Kurokawa; A Ohga; T Ohta; K Sawabe
Journal:  J Physiol       Date:  1990-11       Impact factor: 5.182

4.  A functional role for the 'fibroblast-like cells' in gastrointestinal smooth muscles.

Authors:  Masaaki Kurahashi; Haifeng Zheng; Laura Dwyer; Sean M Ward; Sang Don Koh; Kenton M Sanders
Journal:  J Physiol       Date:  2010-12-20       Impact factor: 5.182

5.  Participation of prostaglandin E2 in the purinergic neurotransmission of gut.

Authors:  J T Cheng; K Shinozuka
Journal:  Gut       Date:  1987-12       Impact factor: 23.059

6.  Neuromuscular blocking agents inhibit receptor-mediated increases in the potassium permeability of intestinal smooth muscle.

Authors:  P R Gater; D G Haylett; D H Jenkinson
Journal:  Br J Pharmacol       Date:  1985-12       Impact factor: 8.739

7.  Modification by charybdotoxin and apamin of spontaneous electrical and mechanical activity of the circular smooth muscle of the guinea-pig stomach.

Authors:  K Suzuki; K M Ito; Y Minayoshi; H Suzuki; M Asano; K Ito
Journal:  Br J Pharmacol       Date:  1993-07       Impact factor: 8.739

8.  The control of 86Rb efflux from rat isolated pancreatic islets by the sulphonylureas tolbutamide and glibenclamide.

Authors:  E K Matthews; P A Shotton
Journal:  Br J Pharmacol       Date:  1984-07       Impact factor: 8.739

9.  Pharmacological identification of different inhibitory mediators involved in the innervation of the internal anal sphincter.

Authors:  A Tøttrup; M A Knudsen; F Hanberg Sørensen; E B Glavind
Journal:  Br J Pharmacol       Date:  1995-05       Impact factor: 8.739

10.  Inhibition of rat colon contractility by prostacyclin (IP-) receptor agonists: involvement of NANC neurotransmission.

Authors:  Y M Qian; R L Jones
Journal:  Br J Pharmacol       Date:  1995-05       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.